nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP2B6—Thiotepa—urinary bladder cancer	0.213	0.501	CbGbCtD
Tramadol—CYP3A4—Thiotepa—urinary bladder cancer	0.0653	0.154	CbGbCtD
Tramadol—CYP2B6—Cisplatin—urinary bladder cancer	0.0586	0.138	CbGbCtD
Tramadol—CYP2B6—Doxorubicin—urinary bladder cancer	0.0393	0.0926	CbGbCtD
Tramadol—CHRM3—ureter—urinary bladder cancer	0.0274	0.282	CbGeAlD
Tramadol—CHRM3—muscle of abdomen—urinary bladder cancer	0.0198	0.203	CbGeAlD
Tramadol—CYP2D6—Doxorubicin—urinary bladder cancer	0.019	0.0447	CbGbCtD
Tramadol—CYP3A4—Etoposide—urinary bladder cancer	0.0177	0.0417	CbGbCtD
Tramadol—CYP3A4—Doxorubicin—urinary bladder cancer	0.0121	0.0284	CbGbCtD
Tramadol—OPRK1—prostate gland—urinary bladder cancer	0.00607	0.0624	CbGeAlD
Tramadol—CYP3A4—urine—urinary bladder cancer	0.0049	0.0504	CbGeAlD
Tramadol—CYP2D6—urine—urinary bladder cancer	0.00482	0.0496	CbGeAlD
Tramadol—OPRD1—renal system—urinary bladder cancer	0.00431	0.0444	CbGeAlD
Tramadol—OPRK1—female reproductive system—urinary bladder cancer	0.00331	0.0341	CbGeAlD
Tramadol—CHRM3—prostate gland—urinary bladder cancer	0.0032	0.0329	CbGeAlD
Tramadol—CHRM3—smooth muscle tissue—urinary bladder cancer	0.00227	0.0233	CbGeAlD
Tramadol—CHRM3—renal system—urinary bladder cancer	0.00218	0.0224	CbGeAlD
Tramadol—CHRM3—urethra—urinary bladder cancer	0.00214	0.022	CbGeAlD
Tramadol—HTR2C—female reproductive system—urinary bladder cancer	0.00207	0.0213	CbGeAlD
Tramadol—SLC6A4—female reproductive system—urinary bladder cancer	0.00196	0.0202	CbGeAlD
Tramadol—CHRM3—female reproductive system—urinary bladder cancer	0.00175	0.018	CbGeAlD
Tramadol—SLC6A2—female reproductive system—urinary bladder cancer	0.00173	0.0178	CbGeAlD
Tramadol—CYP2B6—renal system—urinary bladder cancer	0.00159	0.0163	CbGeAlD
Tramadol—CYP2B6—female reproductive system—urinary bladder cancer	0.00127	0.0131	CbGeAlD
Tramadol—CYP3A4—renal system—urinary bladder cancer	0.0012	0.0123	CbGeAlD
Tramadol—CYP2D6—renal system—urinary bladder cancer	0.00118	0.0121	CbGeAlD
Tramadol—CYP2B6—vagina—urinary bladder cancer	0.00115	0.0118	CbGeAlD
Tramadol—SLC6A2—lymph node—urinary bladder cancer	0.00101	0.0104	CbGeAlD
Tramadol—CYP3A4—female reproductive system—urinary bladder cancer	0.00096	0.00988	CbGeAlD
Tramadol—CYP2D6—female reproductive system—urinary bladder cancer	0.000945	0.00972	CbGeAlD
Tramadol—Haematuria—Doxorubicin—urinary bladder cancer	0.000165	0.000373	CcSEcCtD
Tramadol—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000165	0.000373	CcSEcCtD
Tramadol—Urethral disorder—Epirubicin—urinary bladder cancer	0.000165	0.000372	CcSEcCtD
Tramadol—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000164	0.00037	CcSEcCtD
Tramadol—Epistaxis—Doxorubicin—urinary bladder cancer	0.000164	0.000369	CcSEcCtD
Tramadol—Angiopathy—Methotrexate—urinary bladder cancer	0.000163	0.000368	CcSEcCtD
Tramadol—Sinusitis—Doxorubicin—urinary bladder cancer	0.000163	0.000367	CcSEcCtD
Tramadol—Immune system disorder—Methotrexate—urinary bladder cancer	0.000163	0.000366	CcSEcCtD
Tramadol—Dizziness—Fluorouracil—urinary bladder cancer	0.000163	0.000366	CcSEcCtD
Tramadol—Visual impairment—Epirubicin—urinary bladder cancer	0.000162	0.000366	CcSEcCtD
Tramadol—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000162	0.000365	CcSEcCtD
Tramadol—Chills—Methotrexate—urinary bladder cancer	0.000161	0.000364	CcSEcCtD
Tramadol—Diarrhoea—Cisplatin—urinary bladder cancer	0.000159	0.000359	CcSEcCtD
Tramadol—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000159	0.000359	CcSEcCtD
Tramadol—Vomiting—Gemcitabine—urinary bladder cancer	0.000159	0.000358	CcSEcCtD
Tramadol—Bradycardia—Doxorubicin—urinary bladder cancer	0.000159	0.000357	CcSEcCtD
Tramadol—Mental disorder—Methotrexate—urinary bladder cancer	0.000158	0.000355	CcSEcCtD
Tramadol—Rash—Gemcitabine—urinary bladder cancer	0.000158	0.000355	CcSEcCtD
Tramadol—Dermatitis—Gemcitabine—urinary bladder cancer	0.000157	0.000355	CcSEcCtD
Tramadol—Eye disorder—Epirubicin—urinary bladder cancer	0.000157	0.000354	CcSEcCtD
Tramadol—Hypersensitivity—Etoposide—urinary bladder cancer	0.000157	0.000354	CcSEcCtD
Tramadol—Tinnitus—Epirubicin—urinary bladder cancer	0.000157	0.000354	CcSEcCtD
Tramadol—Malnutrition—Methotrexate—urinary bladder cancer	0.000157	0.000353	CcSEcCtD
Tramadol—Erythema—Methotrexate—urinary bladder cancer	0.000157	0.000353	CcSEcCtD
Tramadol—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000157	0.000353	CcSEcCtD
Tramadol—Headache—Gemcitabine—urinary bladder cancer	0.000157	0.000353	CcSEcCtD
Tramadol—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000156	0.000352	CcSEcCtD
Tramadol—Flushing—Epirubicin—urinary bladder cancer	0.000156	0.000352	CcSEcCtD
Tramadol—Vomiting—Fluorouracil—urinary bladder cancer	0.000156	0.000352	CcSEcCtD
Tramadol—Rhinitis—Doxorubicin—urinary bladder cancer	0.000156	0.000352	CcSEcCtD
Tramadol—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000156	0.000351	CcSEcCtD
Tramadol—Hepatitis—Doxorubicin—urinary bladder cancer	0.000156	0.000351	CcSEcCtD
Tramadol—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000155	0.000349	CcSEcCtD
Tramadol—Rash—Fluorouracil—urinary bladder cancer	0.000155	0.000349	CcSEcCtD
Tramadol—Dermatitis—Fluorouracil—urinary bladder cancer	0.000155	0.000349	CcSEcCtD
Tramadol—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000155	0.000348	CcSEcCtD
Tramadol—Headache—Fluorouracil—urinary bladder cancer	0.000154	0.000347	CcSEcCtD
Tramadol—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000154	0.000347	CcSEcCtD
Tramadol—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000153	0.000346	CcSEcCtD
Tramadol—Dysgeusia—Methotrexate—urinary bladder cancer	0.000153	0.000346	CcSEcCtD
Tramadol—Asthenia—Etoposide—urinary bladder cancer	0.000153	0.000345	CcSEcCtD
Tramadol—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000153	0.000345	CcSEcCtD
Tramadol—Angiopathy—Epirubicin—urinary bladder cancer	0.000153	0.000344	CcSEcCtD
Tramadol—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000153	0.000344	CcSEcCtD
Tramadol—Immune system disorder—Epirubicin—urinary bladder cancer	0.000152	0.000343	CcSEcCtD
Tramadol—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000152	0.000342	CcSEcCtD
Tramadol—Back pain—Methotrexate—urinary bladder cancer	0.000152	0.000341	CcSEcCtD
Tramadol—Chills—Epirubicin—urinary bladder cancer	0.000151	0.00034	CcSEcCtD
Tramadol—Pruritus—Etoposide—urinary bladder cancer	0.000151	0.00034	CcSEcCtD
Tramadol—Arrhythmia—Epirubicin—urinary bladder cancer	0.00015	0.000339	CcSEcCtD
Tramadol—Visual impairment—Doxorubicin—urinary bladder cancer	0.00015	0.000338	CcSEcCtD
Tramadol—Nausea—Gemcitabine—urinary bladder cancer	0.000148	0.000334	CcSEcCtD
Tramadol—Vomiting—Cisplatin—urinary bladder cancer	0.000148	0.000334	CcSEcCtD
Tramadol—Vision blurred—Methotrexate—urinary bladder cancer	0.000148	0.000333	CcSEcCtD
Tramadol—Mental disorder—Epirubicin—urinary bladder cancer	0.000148	0.000332	CcSEcCtD
Tramadol—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000147	0.000332	CcSEcCtD
Tramadol—Rash—Cisplatin—urinary bladder cancer	0.000147	0.000331	CcSEcCtD
Tramadol—Dermatitis—Cisplatin—urinary bladder cancer	0.000147	0.000331	CcSEcCtD
Tramadol—Erythema—Epirubicin—urinary bladder cancer	0.000147	0.00033	CcSEcCtD
Tramadol—Malnutrition—Epirubicin—urinary bladder cancer	0.000147	0.00033	CcSEcCtD
Tramadol—Diarrhoea—Etoposide—urinary bladder cancer	0.000146	0.000329	CcSEcCtD
Tramadol—Nausea—Fluorouracil—urinary bladder cancer	0.000146	0.000329	CcSEcCtD
Tramadol—Eye disorder—Doxorubicin—urinary bladder cancer	0.000146	0.000328	CcSEcCtD
Tramadol—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000145	0.000327	CcSEcCtD
Tramadol—Tinnitus—Doxorubicin—urinary bladder cancer	0.000145	0.000327	CcSEcCtD
Tramadol—Anaemia—Methotrexate—urinary bladder cancer	0.000145	0.000326	CcSEcCtD
Tramadol—Flushing—Doxorubicin—urinary bladder cancer	0.000145	0.000326	CcSEcCtD
Tramadol—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000145	0.000326	CcSEcCtD
Tramadol—Flatulence—Epirubicin—urinary bladder cancer	0.000144	0.000325	CcSEcCtD
Tramadol—Tension—Epirubicin—urinary bladder cancer	0.000144	0.000324	CcSEcCtD
Tramadol—Dysgeusia—Epirubicin—urinary bladder cancer	0.000144	0.000323	CcSEcCtD
Tramadol—Nervousness—Epirubicin—urinary bladder cancer	0.000142	0.000321	CcSEcCtD
Tramadol—Back pain—Epirubicin—urinary bladder cancer	0.000142	0.000319	CcSEcCtD
Tramadol—Angiopathy—Doxorubicin—urinary bladder cancer	0.000141	0.000318	CcSEcCtD
Tramadol—Malaise—Methotrexate—urinary bladder cancer	0.000141	0.000318	CcSEcCtD
Tramadol—Dizziness—Etoposide—urinary bladder cancer	0.000141	0.000318	CcSEcCtD
Tramadol—Muscle spasms—Epirubicin—urinary bladder cancer	0.000141	0.000317	CcSEcCtD
Tramadol—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000141	0.000317	CcSEcCtD
Tramadol—Vertigo—Methotrexate—urinary bladder cancer	0.000141	0.000317	CcSEcCtD
Tramadol—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00014	0.000316	CcSEcCtD
Tramadol—Chills—Doxorubicin—urinary bladder cancer	0.00014	0.000315	CcSEcCtD
Tramadol—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000139	0.000314	CcSEcCtD
Tramadol—Nausea—Cisplatin—urinary bladder cancer	0.000138	0.000312	CcSEcCtD
Tramadol—Vision blurred—Epirubicin—urinary bladder cancer	0.000138	0.000311	CcSEcCtD
Tramadol—Cough—Methotrexate—urinary bladder cancer	0.000137	0.000308	CcSEcCtD
Tramadol—Mental disorder—Doxorubicin—urinary bladder cancer	0.000137	0.000307	CcSEcCtD
Tramadol—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000136	0.000306	CcSEcCtD
Tramadol—Convulsion—Methotrexate—urinary bladder cancer	0.000136	0.000306	CcSEcCtD
Tramadol—Vomiting—Etoposide—urinary bladder cancer	0.000136	0.000306	CcSEcCtD
Tramadol—Malnutrition—Doxorubicin—urinary bladder cancer	0.000136	0.000306	CcSEcCtD
Tramadol—Erythema—Doxorubicin—urinary bladder cancer	0.000136	0.000306	CcSEcCtD
Tramadol—Anaemia—Epirubicin—urinary bladder cancer	0.000135	0.000305	CcSEcCtD
Tramadol—Agitation—Epirubicin—urinary bladder cancer	0.000135	0.000303	CcSEcCtD
Tramadol—Rash—Etoposide—urinary bladder cancer	0.000135	0.000303	CcSEcCtD
Tramadol—Dermatitis—Etoposide—urinary bladder cancer	0.000134	0.000303	CcSEcCtD
Tramadol—Headache—Etoposide—urinary bladder cancer	0.000134	0.000301	CcSEcCtD
Tramadol—Flatulence—Doxorubicin—urinary bladder cancer	0.000134	0.000301	CcSEcCtD
Tramadol—Chest pain—Methotrexate—urinary bladder cancer	0.000133	0.0003	CcSEcCtD
Tramadol—Myalgia—Methotrexate—urinary bladder cancer	0.000133	0.0003	CcSEcCtD
Tramadol—Arthralgia—Methotrexate—urinary bladder cancer	0.000133	0.0003	CcSEcCtD
Tramadol—Tension—Doxorubicin—urinary bladder cancer	0.000133	0.0003	CcSEcCtD
Tramadol—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000133	0.000299	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000132	0.000298	CcSEcCtD
Tramadol—Malaise—Epirubicin—urinary bladder cancer	0.000132	0.000298	CcSEcCtD
Tramadol—Discomfort—Methotrexate—urinary bladder cancer	0.000132	0.000297	CcSEcCtD
Tramadol—Nervousness—Doxorubicin—urinary bladder cancer	0.000132	0.000297	CcSEcCtD
Tramadol—Vertigo—Epirubicin—urinary bladder cancer	0.000132	0.000297	CcSEcCtD
Tramadol—Syncope—Epirubicin—urinary bladder cancer	0.000131	0.000296	CcSEcCtD
Tramadol—Back pain—Doxorubicin—urinary bladder cancer	0.000131	0.000296	CcSEcCtD
Tramadol—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00013	0.000294	CcSEcCtD
Tramadol—Palpitations—Epirubicin—urinary bladder cancer	0.00013	0.000292	CcSEcCtD
Tramadol—Confusional state—Methotrexate—urinary bladder cancer	0.000129	0.00029	CcSEcCtD
Tramadol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000129	0.00029	CcSEcCtD
Tramadol—Cough—Epirubicin—urinary bladder cancer	0.000128	0.000288	CcSEcCtD
Tramadol—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000128	0.000288	CcSEcCtD
Tramadol—Vision blurred—Doxorubicin—urinary bladder cancer	0.000128	0.000288	CcSEcCtD
Tramadol—Convulsion—Epirubicin—urinary bladder cancer	0.000127	0.000286	CcSEcCtD
Tramadol—Infection—Methotrexate—urinary bladder cancer	0.000127	0.000286	CcSEcCtD
Tramadol—Nausea—Etoposide—urinary bladder cancer	0.000127	0.000286	CcSEcCtD
Tramadol—Hypertension—Epirubicin—urinary bladder cancer	0.000127	0.000285	CcSEcCtD
Tramadol—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000126	0.000283	CcSEcCtD
Tramadol—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000125	0.000282	CcSEcCtD
Tramadol—Anaemia—Doxorubicin—urinary bladder cancer	0.000125	0.000282	CcSEcCtD
Tramadol—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000125	0.000282	CcSEcCtD
Tramadol—Myalgia—Epirubicin—urinary bladder cancer	0.000125	0.000281	CcSEcCtD
Tramadol—Arthralgia—Epirubicin—urinary bladder cancer	0.000125	0.000281	CcSEcCtD
Tramadol—Chest pain—Epirubicin—urinary bladder cancer	0.000125	0.000281	CcSEcCtD
Tramadol—Agitation—Doxorubicin—urinary bladder cancer	0.000125	0.000281	CcSEcCtD
Tramadol—Anxiety—Epirubicin—urinary bladder cancer	0.000124	0.00028	CcSEcCtD
Tramadol—Skin disorder—Methotrexate—urinary bladder cancer	0.000124	0.00028	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000124	0.000279	CcSEcCtD
Tramadol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000124	0.000278	CcSEcCtD
Tramadol—Discomfort—Epirubicin—urinary bladder cancer	0.000123	0.000278	CcSEcCtD
Tramadol—Malaise—Doxorubicin—urinary bladder cancer	0.000122	0.000276	CcSEcCtD
Tramadol—Dry mouth—Epirubicin—urinary bladder cancer	0.000122	0.000275	CcSEcCtD
Tramadol—Vertigo—Doxorubicin—urinary bladder cancer	0.000122	0.000275	CcSEcCtD
Tramadol—Anorexia—Methotrexate—urinary bladder cancer	0.000122	0.000275	CcSEcCtD
Tramadol—Syncope—Doxorubicin—urinary bladder cancer	0.000122	0.000274	CcSEcCtD
Tramadol—Confusional state—Epirubicin—urinary bladder cancer	0.000121	0.000272	CcSEcCtD
Tramadol—Palpitations—Doxorubicin—urinary bladder cancer	0.00012	0.00027	CcSEcCtD
Tramadol—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00012	0.000269	CcSEcCtD
Tramadol—Hypotension—Methotrexate—urinary bladder cancer	0.000119	0.000269	CcSEcCtD
Tramadol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000119	0.000269	CcSEcCtD
Tramadol—Infection—Epirubicin—urinary bladder cancer	0.000119	0.000268	CcSEcCtD
Tramadol—Cough—Doxorubicin—urinary bladder cancer	0.000118	0.000267	CcSEcCtD
Tramadol—Shock—Epirubicin—urinary bladder cancer	0.000118	0.000265	CcSEcCtD
Tramadol—Convulsion—Doxorubicin—urinary bladder cancer	0.000118	0.000265	CcSEcCtD
Tramadol—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000117	0.000264	CcSEcCtD
Tramadol—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000117	0.000264	CcSEcCtD
Tramadol—Hypertension—Doxorubicin—urinary bladder cancer	0.000117	0.000264	CcSEcCtD
Tramadol—Tachycardia—Epirubicin—urinary bladder cancer	0.000117	0.000263	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000116	0.000262	CcSEcCtD
Tramadol—Skin disorder—Epirubicin—urinary bladder cancer	0.000116	0.000262	CcSEcCtD
Tramadol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000116	0.000261	CcSEcCtD
Tramadol—Insomnia—Methotrexate—urinary bladder cancer	0.000116	0.00026	CcSEcCtD
Tramadol—Chest pain—Doxorubicin—urinary bladder cancer	0.000115	0.00026	CcSEcCtD
Tramadol—Arthralgia—Doxorubicin—urinary bladder cancer	0.000115	0.00026	CcSEcCtD
Tramadol—Myalgia—Doxorubicin—urinary bladder cancer	0.000115	0.00026	CcSEcCtD
Tramadol—Anxiety—Doxorubicin—urinary bladder cancer	0.000115	0.000259	CcSEcCtD
Tramadol—Paraesthesia—Methotrexate—urinary bladder cancer	0.000115	0.000259	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000115	0.000258	CcSEcCtD
Tramadol—Discomfort—Doxorubicin—urinary bladder cancer	0.000114	0.000257	CcSEcCtD
Tramadol—Anorexia—Epirubicin—urinary bladder cancer	0.000114	0.000257	CcSEcCtD
Tramadol—Dyspnoea—Methotrexate—urinary bladder cancer	0.000114	0.000257	CcSEcCtD
Tramadol—Somnolence—Methotrexate—urinary bladder cancer	0.000114	0.000256	CcSEcCtD
Tramadol—Dry mouth—Doxorubicin—urinary bladder cancer	0.000113	0.000254	CcSEcCtD
Tramadol—Dyspepsia—Methotrexate—urinary bladder cancer	0.000113	0.000253	CcSEcCtD
Tramadol—Hypotension—Epirubicin—urinary bladder cancer	0.000112	0.000252	CcSEcCtD
Tramadol—Confusional state—Doxorubicin—urinary bladder cancer	0.000112	0.000251	CcSEcCtD
Tramadol—Decreased appetite—Methotrexate—urinary bladder cancer	0.000111	0.00025	CcSEcCtD
Tramadol—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000111	0.000249	CcSEcCtD
Tramadol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00011	0.000249	CcSEcCtD
Tramadol—Fatigue—Methotrexate—urinary bladder cancer	0.00011	0.000248	CcSEcCtD
Tramadol—Infection—Doxorubicin—urinary bladder cancer	0.00011	0.000248	CcSEcCtD
Tramadol—Pain—Methotrexate—urinary bladder cancer	0.000109	0.000246	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000109	0.000246	CcSEcCtD
Tramadol—Shock—Doxorubicin—urinary bladder cancer	0.000109	0.000245	CcSEcCtD
Tramadol—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000109	0.000245	CcSEcCtD
Tramadol—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000108	0.000244	CcSEcCtD
Tramadol—Insomnia—Epirubicin—urinary bladder cancer	0.000108	0.000244	CcSEcCtD
Tramadol—Tachycardia—Doxorubicin—urinary bladder cancer	0.000108	0.000243	CcSEcCtD
Tramadol—Skin disorder—Doxorubicin—urinary bladder cancer	0.000108	0.000242	CcSEcCtD
Tramadol—Paraesthesia—Epirubicin—urinary bladder cancer	0.000107	0.000242	CcSEcCtD
Tramadol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000107	0.000241	CcSEcCtD
Tramadol—Dyspnoea—Epirubicin—urinary bladder cancer	0.000107	0.00024	CcSEcCtD
Tramadol—Somnolence—Epirubicin—urinary bladder cancer	0.000106	0.00024	CcSEcCtD
Tramadol—Anorexia—Doxorubicin—urinary bladder cancer	0.000106	0.000238	CcSEcCtD
Tramadol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000105	0.000237	CcSEcCtD
Tramadol—Dyspepsia—Epirubicin—urinary bladder cancer	0.000105	0.000237	CcSEcCtD
Tramadol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000105	0.000235	CcSEcCtD
Tramadol—Decreased appetite—Epirubicin—urinary bladder cancer	0.000104	0.000234	CcSEcCtD
Tramadol—Hypotension—Doxorubicin—urinary bladder cancer	0.000103	0.000233	CcSEcCtD
Tramadol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000103	0.000233	CcSEcCtD
Tramadol—Fatigue—Epirubicin—urinary bladder cancer	0.000103	0.000232	CcSEcCtD
Tramadol—Pain—Epirubicin—urinary bladder cancer	0.000102	0.00023	CcSEcCtD
Tramadol—Constipation—Epirubicin—urinary bladder cancer	0.000102	0.00023	CcSEcCtD
Tramadol—Urticaria—Methotrexate—urinary bladder cancer	0.000102	0.000229	CcSEcCtD
Tramadol—Abdominal pain—Methotrexate—urinary bladder cancer	0.000101	0.000228	CcSEcCtD
Tramadol—Body temperature increased—Methotrexate—urinary bladder cancer	0.000101	0.000228	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000101	0.000227	CcSEcCtD
Tramadol—Insomnia—Doxorubicin—urinary bladder cancer	0.0001	0.000226	CcSEcCtD
Tramadol—Paraesthesia—Doxorubicin—urinary bladder cancer	9.94e-05	0.000224	CcSEcCtD
Tramadol—Dyspnoea—Doxorubicin—urinary bladder cancer	9.87e-05	0.000222	CcSEcCtD
Tramadol—Feeling abnormal—Epirubicin—urinary bladder cancer	9.86e-05	0.000222	CcSEcCtD
Tramadol—Somnolence—Doxorubicin—urinary bladder cancer	9.84e-05	0.000222	CcSEcCtD
Tramadol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	9.78e-05	0.00022	CcSEcCtD
Tramadol—Dyspepsia—Doxorubicin—urinary bladder cancer	9.74e-05	0.000219	CcSEcCtD
Tramadol—Decreased appetite—Doxorubicin—urinary bladder cancer	9.62e-05	0.000217	CcSEcCtD
Tramadol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	9.56e-05	0.000215	CcSEcCtD
Tramadol—Fatigue—Doxorubicin—urinary bladder cancer	9.54e-05	0.000215	CcSEcCtD
Tramadol—Urticaria—Epirubicin—urinary bladder cancer	9.5e-05	0.000214	CcSEcCtD
Tramadol—Pain—Doxorubicin—urinary bladder cancer	9.47e-05	0.000213	CcSEcCtD
Tramadol—Constipation—Doxorubicin—urinary bladder cancer	9.47e-05	0.000213	CcSEcCtD
Tramadol—Body temperature increased—Epirubicin—urinary bladder cancer	9.46e-05	0.000213	CcSEcCtD
Tramadol—Abdominal pain—Epirubicin—urinary bladder cancer	9.46e-05	0.000213	CcSEcCtD
Tramadol—Hypersensitivity—Methotrexate—urinary bladder cancer	9.42e-05	0.000212	CcSEcCtD
Tramadol—Asthenia—Methotrexate—urinary bladder cancer	9.17e-05	0.000207	CcSEcCtD
Tramadol—Feeling abnormal—Doxorubicin—urinary bladder cancer	9.12e-05	0.000205	CcSEcCtD
Tramadol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	9.05e-05	0.000204	CcSEcCtD
Tramadol—Pruritus—Methotrexate—urinary bladder cancer	9.04e-05	0.000204	CcSEcCtD
Tramadol—Hypersensitivity—Epirubicin—urinary bladder cancer	8.81e-05	0.000199	CcSEcCtD
Tramadol—Urticaria—Doxorubicin—urinary bladder cancer	8.79e-05	0.000198	CcSEcCtD
Tramadol—Body temperature increased—Doxorubicin—urinary bladder cancer	8.75e-05	0.000197	CcSEcCtD
Tramadol—Abdominal pain—Doxorubicin—urinary bladder cancer	8.75e-05	0.000197	CcSEcCtD
Tramadol—Diarrhoea—Methotrexate—urinary bladder cancer	8.75e-05	0.000197	CcSEcCtD
Tramadol—Asthenia—Epirubicin—urinary bladder cancer	8.58e-05	0.000193	CcSEcCtD
Tramadol—Pruritus—Epirubicin—urinary bladder cancer	8.46e-05	0.000191	CcSEcCtD
Tramadol—Dizziness—Methotrexate—urinary bladder cancer	8.45e-05	0.00019	CcSEcCtD
Tramadol—Diarrhoea—Epirubicin—urinary bladder cancer	8.19e-05	0.000184	CcSEcCtD
Tramadol—Hypersensitivity—Doxorubicin—urinary bladder cancer	8.16e-05	0.000184	CcSEcCtD
Tramadol—Vomiting—Methotrexate—urinary bladder cancer	8.13e-05	0.000183	CcSEcCtD
Tramadol—Rash—Methotrexate—urinary bladder cancer	8.06e-05	0.000182	CcSEcCtD
Tramadol—Dermatitis—Methotrexate—urinary bladder cancer	8.05e-05	0.000181	CcSEcCtD
Tramadol—Headache—Methotrexate—urinary bladder cancer	8.01e-05	0.00018	CcSEcCtD
Tramadol—Asthenia—Doxorubicin—urinary bladder cancer	7.94e-05	0.000179	CcSEcCtD
Tramadol—Dizziness—Epirubicin—urinary bladder cancer	7.91e-05	0.000178	CcSEcCtD
Tramadol—Pruritus—Doxorubicin—urinary bladder cancer	7.83e-05	0.000176	CcSEcCtD
Tramadol—Vomiting—Epirubicin—urinary bladder cancer	7.61e-05	0.000171	CcSEcCtD
Tramadol—Nausea—Methotrexate—urinary bladder cancer	7.59e-05	0.000171	CcSEcCtD
Tramadol—Diarrhoea—Doxorubicin—urinary bladder cancer	7.57e-05	0.000171	CcSEcCtD
Tramadol—Rash—Epirubicin—urinary bladder cancer	7.54e-05	0.00017	CcSEcCtD
Tramadol—Dermatitis—Epirubicin—urinary bladder cancer	7.54e-05	0.00017	CcSEcCtD
Tramadol—Headache—Epirubicin—urinary bladder cancer	7.49e-05	0.000169	CcSEcCtD
Tramadol—Dizziness—Doxorubicin—urinary bladder cancer	7.32e-05	0.000165	CcSEcCtD
Tramadol—Nausea—Epirubicin—urinary bladder cancer	7.11e-05	0.00016	CcSEcCtD
Tramadol—Vomiting—Doxorubicin—urinary bladder cancer	7.04e-05	0.000159	CcSEcCtD
Tramadol—Rash—Doxorubicin—urinary bladder cancer	6.98e-05	0.000157	CcSEcCtD
Tramadol—Dermatitis—Doxorubicin—urinary bladder cancer	6.97e-05	0.000157	CcSEcCtD
Tramadol—Headache—Doxorubicin—urinary bladder cancer	6.93e-05	0.000156	CcSEcCtD
Tramadol—Nausea—Doxorubicin—urinary bladder cancer	6.58e-05	0.000148	CcSEcCtD
Tramadol—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	2.36e-05	0.000686	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—RHOA—urinary bladder cancer	2.3e-05	0.000668	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CXCL8—urinary bladder cancer	2.28e-05	0.000661	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—RRM2—urinary bladder cancer	2.27e-05	0.000659	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NAT2—urinary bladder cancer	2.26e-05	0.000657	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RBX1—urinary bladder cancer	2.25e-05	0.000654	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	2.23e-05	0.000648	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—S100B—urinary bladder cancer	2.2e-05	0.00064	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	2.18e-05	0.000631	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TSC1—urinary bladder cancer	2.12e-05	0.000615	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ENO2—urinary bladder cancer	2.1e-05	0.00061	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—HPGDS—urinary bladder cancer	2.1e-05	0.00061	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—RHOA—urinary bladder cancer	2.09e-05	0.000607	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GSTT1—urinary bladder cancer	2.04e-05	0.000592	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	2.04e-05	0.000592	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.02e-05	0.000587	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—RHOA—urinary bladder cancer	2.02e-05	0.000586	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—JAG1—urinary bladder cancer	2.02e-05	0.000586	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NCOR1—urinary bladder cancer	1.98e-05	0.000575	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.98e-05	0.000575	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CXCL8—urinary bladder cancer	1.96e-05	0.000569	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—RRM2—urinary bladder cancer	1.95e-05	0.000567	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RBX1—urinary bladder cancer	1.94e-05	0.000562	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—S100B—urinary bladder cancer	1.93e-05	0.000561	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—IL2—urinary bladder cancer	1.93e-05	0.000561	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.88e-05	0.000545	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.88e-05	0.000545	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CXCL8—urinary bladder cancer	1.84e-05	0.000533	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—RHOA—urinary bladder cancer	1.83e-05	0.000532	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TSC1—urinary bladder cancer	1.82e-05	0.000528	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ENO2—urinary bladder cancer	1.81e-05	0.000525	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	1.81e-05	0.000525	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.77e-05	0.000514	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	1.75e-05	0.000509	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL2—urinary bladder cancer	1.75e-05	0.000509	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TERT—urinary bladder cancer	1.75e-05	0.000507	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.74e-05	0.000505	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NCOR1—urinary bladder cancer	1.74e-05	0.000505	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—JAG1—urinary bladder cancer	1.73e-05	0.000503	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.72e-05	0.000498	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—RHOA—urinary bladder cancer	1.71e-05	0.000495	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NQO1—urinary bladder cancer	1.7e-05	0.000492	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—IL2—urinary bladder cancer	1.69e-05	0.000492	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RBX1—urinary bladder cancer	1.67e-05	0.000484	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—S100B—urinary bladder cancer	1.63e-05	0.000474	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CXCL8—urinary bladder cancer	1.61e-05	0.000467	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—FGFR3—urinary bladder cancer	1.6e-05	0.000465	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.57e-05	0.000457	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TSC1—urinary bladder cancer	1.57e-05	0.000455	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ESR1—urinary bladder cancer	1.56e-05	0.000452	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—RHOA—urinary bladder cancer	1.55e-05	0.00045	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.55e-05	0.000449	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL2—urinary bladder cancer	1.54e-05	0.000446	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TERT—urinary bladder cancer	1.53e-05	0.000445	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.5e-05	0.000435	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—JAG1—urinary bladder cancer	1.49e-05	0.000433	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NCOR1—urinary bladder cancer	1.47e-05	0.000426	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—RHOA—urinary bladder cancer	1.46e-05	0.000425	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.46e-05	0.000424	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.46e-05	0.000423	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—IL2—urinary bladder cancer	1.43e-05	0.000415	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.42e-05	0.000413	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GSTP1—urinary bladder cancer	1.41e-05	0.00041	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—FGFR3—urinary bladder cancer	1.41e-05	0.000408	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—S100B—urinary bladder cancer	1.4e-05	0.000407	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ESR1—urinary bladder cancer	1.37e-05	0.000396	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CREBBP—urinary bladder cancer	1.36e-05	0.000396	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CXCL8—urinary bladder cancer	1.36e-05	0.000395	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.36e-05	0.000394	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IGF1—urinary bladder cancer	1.35e-05	0.000391	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—EGFR—urinary bladder cancer	1.34e-05	0.000389	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—RHOA—urinary bladder cancer	1.33e-05	0.000386	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—TYMS—urinary bladder cancer	1.31e-05	0.000381	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL2—urinary bladder cancer	1.3e-05	0.000377	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NCOR1—urinary bladder cancer	1.3e-05	0.000377	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GSTM1—urinary bladder cancer	1.3e-05	0.000377	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TERT—urinary bladder cancer	1.29e-05	0.000376	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.29e-05	0.000373	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—KRAS—urinary bladder cancer	1.27e-05	0.000368	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NCOR1—urinary bladder cancer	1.26e-05	0.000366	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—RHOA—urinary bladder cancer	1.26e-05	0.000366	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.26e-05	0.000365	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.26e-05	0.000365	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GPX1—urinary bladder cancer	1.24e-05	0.000361	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RHOA—urinary bladder cancer	1.23e-05	0.000358	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—IL2—urinary bladder cancer	1.23e-05	0.000357	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ERCC2—urinary bladder cancer	1.22e-05	0.000355	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.22e-05	0.000354	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.22e-05	0.000353	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—S100B—urinary bladder cancer	1.21e-05	0.000351	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CREBBP—urinary bladder cancer	1.2e-05	0.000347	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FGFR3—urinary bladder cancer	1.19e-05	0.000345	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IGF1—urinary bladder cancer	1.18e-05	0.000343	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—EGFR—urinary bladder cancer	1.18e-05	0.000341	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CXCL8—urinary bladder cancer	1.17e-05	0.000339	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ESR1—urinary bladder cancer	1.15e-05	0.000335	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—MTHFR—urinary bladder cancer	1.15e-05	0.000333	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—RHOA—urinary bladder cancer	1.15e-05	0.000332	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ERBB2—urinary bladder cancer	1.14e-05	0.000332	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.14e-05	0.00033	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.13e-05	0.000328	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.12e-05	0.000324	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.12e-05	0.000324	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL2—urinary bladder cancer	1.12e-05	0.000324	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TERT—urinary bladder cancer	1.11e-05	0.000323	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—KRAS—urinary bladder cancer	1.11e-05	0.000322	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.11e-05	0.000321	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NCOR1—urinary bladder cancer	1.09e-05	0.000315	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCL8—urinary bladder cancer	1.08e-05	0.000315	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—RHOA—urinary bladder cancer	1.08e-05	0.000314	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—HRAS—urinary bladder cancer	1.08e-05	0.000313	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.07e-05	0.000311	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—IL2—urinary bladder cancer	1.06e-05	0.000307	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.05e-05	0.000305	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL2—urinary bladder cancer	1.04e-05	0.000301	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.03e-05	0.000298	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FGFR3—urinary bladder cancer	1.02e-05	0.000296	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.01e-05	0.000294	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CREBBP—urinary bladder cancer	1.01e-05	0.000294	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCND1—urinary bladder cancer	1.01e-05	0.000293	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCL8—urinary bladder cancer	1.01e-05	0.000292	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ERBB2—urinary bladder cancer	1e-05	0.000291	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IGF1—urinary bladder cancer	9.99e-06	0.00029	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EGFR—urinary bladder cancer	9.94e-06	0.000289	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ESR1—urinary bladder cancer	9.91e-06	0.000288	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	9.88e-06	0.000287	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MMP9—urinary bladder cancer	9.8e-06	0.000285	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CDKN1A—urinary bladder cancer	9.77e-06	0.000284	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PTEN—urinary bladder cancer	9.75e-06	0.000283	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL2—urinary bladder cancer	9.61e-06	0.000279	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TERT—urinary bladder cancer	9.57e-06	0.000278	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCL8—urinary bladder cancer	9.51e-06	0.000276	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HRAS—urinary bladder cancer	9.44e-06	0.000274	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—KRAS—urinary bladder cancer	9.39e-06	0.000273	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARG—urinary bladder cancer	9.31e-06	0.00027	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EP300—urinary bladder cancer	9.3e-06	0.00027	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RHOA—urinary bladder cancer	9.15e-06	0.000266	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2—urinary bladder cancer	9.08e-06	0.000264	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SRC—urinary bladder cancer	9.04e-06	0.000262	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CREBBP—urinary bladder cancer	8.94e-06	0.00026	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—RRM2—urinary bladder cancer	8.88e-06	0.000258	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCND1—urinary bladder cancer	8.86e-06	0.000257	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGFR3—urinary bladder cancer	8.79e-06	0.000255	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CREBBP—urinary bladder cancer	8.69e-06	0.000252	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—urinary bladder cancer	8.6e-06	0.00025	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF1—urinary bladder cancer	8.58e-06	0.000249	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDKN1A—urinary bladder cancer	8.57e-06	0.000249	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTEN—urinary bladder cancer	8.55e-06	0.000248	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—urinary bladder cancer	8.54e-06	0.000248	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ESR1—urinary bladder cancer	8.53e-06	0.000248	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ERBB2—urinary bladder cancer	8.47e-06	0.000246	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	8.45e-06	0.000245	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	8.22e-06	0.000239	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ENO2—urinary bladder cancer	8.22e-06	0.000239	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EP300—urinary bladder cancer	8.15e-06	0.000237	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—urinary bladder cancer	8.1e-06	0.000235	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—KRAS—urinary bladder cancer	8.06e-06	0.000234	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL8—urinary bladder cancer	8.03e-06	0.000233	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARG—urinary bladder cancer	8.01e-06	0.000232	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HRAS—urinary bladder cancer	7.98e-06	0.000232	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	7.97e-06	0.000231	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SRC—urinary bladder cancer	7.93e-06	0.00023	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—urinary bladder cancer	7.92e-06	0.00023	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TYMS—urinary bladder cancer	7.86e-06	0.000228	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RHOA—urinary bladder cancer	7.86e-06	0.000228	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	7.77e-06	0.000225	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	7.77e-06	0.000225	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	7.69e-06	0.000223	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2—urinary bladder cancer	7.68e-06	0.000223	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KRAS—urinary bladder cancer	7.49e-06	0.000217	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCND1—urinary bladder cancer	7.48e-06	0.000217	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CREBBP—urinary bladder cancer	7.48e-06	0.000217	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GPX1—urinary bladder cancer	7.44e-06	0.000216	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF1—urinary bladder cancer	7.39e-06	0.000214	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—urinary bladder cancer	7.35e-06	0.000213	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—urinary bladder cancer	7.32e-06	0.000213	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	7.3e-06	0.000212	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ERBB2—urinary bladder cancer	7.27e-06	0.000211	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—urinary bladder cancer	7.27e-06	0.000211	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	7.24e-06	0.00021	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTEN—urinary bladder cancer	7.22e-06	0.00021	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—urinary bladder cancer	7.1e-06	0.000206	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—urinary bladder cancer	6.95e-06	0.000202	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—KRAS—urinary bladder cancer	6.94e-06	0.000202	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL8—urinary bladder cancer	6.9e-06	0.0002	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EP300—urinary bladder cancer	6.89e-06	0.0002	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	6.87e-06	0.000199	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HRAS—urinary bladder cancer	6.85e-06	0.000199	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RHOA—urinary bladder cancer	6.77e-06	0.000196	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SRC—urinary bladder cancer	6.7e-06	0.000194	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—urinary bladder cancer	6.65e-06	0.000193	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.63e-06	0.000192	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2—urinary bladder cancer	6.59e-06	0.000191	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KRAS—urinary bladder cancer	6.56e-06	0.000191	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCND1—urinary bladder cancer	6.43e-06	0.000187	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTEN—urinary bladder cancer	6.39e-06	0.000185	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HRAS—urinary bladder cancer	6.36e-06	0.000185	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	6.3e-06	0.000183	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ERBB2—urinary bladder cancer	6.26e-06	0.000182	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—urinary bladder cancer	6.24e-06	0.000181	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN1A—urinary bladder cancer	6.22e-06	0.00018	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTEN—urinary bladder cancer	6.2e-06	0.00018	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—EP300—urinary bladder cancer	6.09e-06	0.000177	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—urinary bladder cancer	6e-06	0.000174	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL8—urinary bladder cancer	5.94e-06	0.000172	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EP300—urinary bladder cancer	5.92e-06	0.000172	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HRAS—urinary bladder cancer	5.9e-06	0.000171	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—urinary bladder cancer	5.87e-06	0.00017	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—urinary bladder cancer	5.83e-06	0.000169	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SRC—urinary bladder cancer	5.75e-06	0.000167	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2—urinary bladder cancer	5.68e-06	0.000165	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HRAS—urinary bladder cancer	5.58e-06	0.000162	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARG—urinary bladder cancer	5.57e-06	0.000162	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KRAS—urinary bladder cancer	5.55e-06	0.000161	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCND1—urinary bladder cancer	5.53e-06	0.000161	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.53e-06	0.00016	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTEN—urinary bladder cancer	5.49e-06	0.000159	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—urinary bladder cancer	5.37e-06	0.000156	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN1A—urinary bladder cancer	5.35e-06	0.000155	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	5.35e-06	0.000155	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTEN—urinary bladder cancer	5.34e-06	0.000155	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—EP300—urinary bladder cancer	5.24e-06	0.000152	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—urinary bladder cancer	5.16e-06	0.00015	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.14e-06	0.000149	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EP300—urinary bladder cancer	5.09e-06	0.000148	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.08e-06	0.000147	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.08e-06	0.000147	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—urinary bladder cancer	5.04e-06	0.000146	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SRC—urinary bladder cancer	4.95e-06	0.000144	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—urinary bladder cancer	4.93e-06	0.000143	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.86e-06	0.000141	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.78e-06	0.000139	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KRAS—urinary bladder cancer	4.76e-06	0.000138	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HRAS—urinary bladder cancer	4.72e-06	0.000137	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.49e-06	0.00013	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—urinary bladder cancer	4.44e-06	0.000129	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	4.38e-06	0.000127	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—urinary bladder cancer	4.34e-06	0.000126	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—urinary bladder cancer	4.23e-06	0.000123	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KRAS—urinary bladder cancer	4.1e-06	0.000119	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HRAS—urinary bladder cancer	4.05e-06	0.000118	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.82e-06	0.000111	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—urinary bladder cancer	3.65e-06	0.000106	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.64e-06	0.000106	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.64e-06	0.000106	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.5e-06	0.000101	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HRAS—urinary bladder cancer	3.49e-06	0.000101	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.86e-06	8.31e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.5e-06	7.25e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.38e-06	6.91e-05	CbGpPWpGaD
